Ground Investigation Articles & Analysis
9 news found
AFRN gathers qualitative and quantitative data from real-world settings through ground level investigations, particularly in low- and middle-income countries. ...
The company’s clinical-stage pipeline includes product candidates being evaluated for the treatment of high-risk C. difficile infection, inflammatory bowel diseases, food allergy, liver disease, and cancer. These investigational therapies are grounded in pioneering research – published in leading journals including Science, Nature, and Cell – to ...
BioTissue continues to break new ground with multiple investigational new drug clinical trials underway to secure biologics license applications for indications to address unmet clinical needs in the ocular, orthopedics, and wound management markets. ...
Today, TissueTech is breaking new ground with multiple Investigational New Drug clinical trials underway as the company pursues 351 biologics’ approval for products to treat patients’ unmet clinical needs. ...
Today, TissueTech is breaking new ground with multiple Investigational New Drug clinical trials underway as the company pursues 351 biologics’ approval for products to treat patients’ unmet clinical needs. ...
Today, TissueTech is breaking new ground with multiple Investigational New Drug clinical trials underway as the company pursues 351 biologics’ approval for products to treat patients’ unmet clinical needs. ...
This is the most advanced clinical trial of an investigational drug based on a rationally defined bacterial consortium, a microbiome-based therapeutic approach that delivers orally administered candidates of precisely known composition that can be manufactured with pharmaceutical-grade consistency. ...
About VE202 VE202 is a first-in-class, orally administered, investigational LBP consortium consisting of 16 bacterial strains of the Clostridia class, which were rationally selected to induce immune tolerance in the gut, reverse the gut microbiota abnormalities that are common in patients with IBD, and strengthen the epithelial barrier. ...
EPA's Science to Achieve Results (STAR) grants program will fund the researchers who will be lead investigators of the Childrens Environmental Health Centers created by EPA and the National Institute of Environmental Health Sciences (NIEHS). ...